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Here we have provided evidence that nitric oxide-cyclic GMP (NO-cGMP) signaling regulates neurite length andmigration of immature
neurons derived from themedial ganglionic eminence (MGE).Dlx1/2/ and Lhx6/mousemutants, which exhibitMGE interneuron
migration defects, have reduced expression of the gene encoding the  subunit of a soluble guanylate cyclase (Gucy1A3). Furthermore,
Dlx1/2/mouse mutants have reduced expression of NO synthase 1 (NOS1). Gucy1A3/mice have a transient reduction in cortical
interneuronnumber. Pharmacological inhibitionof soluble guanylate cyclase andNOSactivity rapidly induces neurite retractionofMGE
cells in vitro and in slice culture and robustly inhibits cellmigration from theMGE and caudal ganglionic eminence.We provide evidence
that these cellular phenotypes aremediated by activation of the Rho signaling pathway and inhibition ofmyosin light chain phosphatase
activity.
Introduction
Development of the ganglionic eminences (GEs), which produce
basal ganglia projection neurons and interneurons that migrate
tangentially to distant targets including the cerebral cortex, is
regulated by theDlx transcription factors. Mice lackingDlx1 and
Dlx2 (Dlx1/2/ mutants) have a severe defect in interneuron
migration (Anderson et al., 1997a; Cobos et al., 2007). Likewise,
mice lacking either Lhx6 or Lhx6 and Lhx8 have a partial block in
interneuron migration from one GE, the medial ganglionic emi-
nence (MGE), where many neurons remain as a periventricular
ectopia (Zhao et al., 2008; Flandin et al., 2011).
Analysis of changes in gene expression in the Dlx1/2/ and
Lhx6/mutants has identified candidate regulators of interneu-
ron migration. For instance, the Pak3 kinase is overexpressed in
Dlx1/2/mutants; reducing Pak3 expression inDlx1/2/mu-
tants partially rescued their migratory defect (Cobos et al., 2007).
Reduced Zfhx1b expression inDlx1/2/mutants contributes to
interneuron migration defects (McKinsey et al., 2013). CXCR4
and CXCR7 receptor expression is reduced in theDlx1/2/ and
Lhx6/ mutants, these receptors guiding interneuron migra-
tion in the cortex (Fogarty et al., 2007; Sa´nchez-Alcan˜iz et al.,
2011; Wang et al., 2011). ErbB4 expression is reduced in the
Lhx6/mutants; this receptor tyrosine transduces the chemoat-
tractant signal from neuregulin in promoting migration (Flames
et al., 2004). Finally, Dlx1/2/ repress neuropilin2 expression
(Le et al., 2007; Long et al., 2009a); neuropilins are coreceptors
for semaphorins. Neuropilin/semaphorin signaling, particularly
through Sema3A, is implicated in sorting MGE-derived cortical
and striatal interneurons (Marín et al., 2001; No´brega-Pereira et
al., 2008), and regulating their migration in the cortex (Tama-
maki et al., 2003).
Semaphorins regulate axon guidance and axon/dendrite spec-
ification; Sema3A signaling may mediate these processes at least
in part by increasing cyclic GMP (cGMP) concentration through
“soluble” guanylyl cyclases (sGCs) (Polleux et al., 1998, 2000;
Schmidt et al., 2002; Nishiyama et al., 2003, 2008, 2011; Togashi
et al., 2008; Shelly et al., 2011). In many tissues, including striatal
medium spiny neurons, sGC are activated by nitric oxide (NO)
(Denninger andMarletta, 1999; Lin et al., 2010). cGMPpromotes
slime mold cell migration (Sato et al., 2009).
Here we have explored whether the NO-cGMP signaling sys-
tem regulates themigration of immature neurons in the develop-
ing telencephalon. Preliminary analyses of Dlx1/2/ mutants
showed that expression of the  subunit of sGC (Gucy1A3) was
decreased in the E15.5 GEs (Long et al., 2009a). Herein we dem-
onstrate that Gucy1A3 is expressed in the dorsal MGE, the pri-
mordium where cortical interneurons are generated, where its
expression is reduced in Dlx1/2/ and Lhx6/ mutants. We
show that NOS1 (nNOS) expression in the MGE is lost in the
Dlx1/2/mutants. We find thatGucy1A3/mice have a tran-
sient prenatal reduction in cortical interneuron number. Fur-
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thermore, pharmacological inhibition of
sGC and NOS activity robustly inhibits
cell migration from the MGE and caudal
ganglionic eminence (CGE) and rapidly
induces neurite retraction of MGE cells in
vitro and in slice culture. We provide evi-
dence that these cellular phenotypes are
mediated by activation of the Rho signal-
ing pathway and inhibition of myosin
light chain phosphatase (MLCP) activity
(see Fig. 14).
Materials andMethods
Animals and tissue preparation. The following
mouse strains (of either sex) were used and
genotyped as described in the associated refer-
ences: Dlx1/2/ (Anderson et al., 1997a),
Lhx6/PLAP (Choi et al., 2005), Lhx6-GFP
(http://www.gensat.org/index.html), Gucy1A3/
(Buys et al., 2008), and NOS1/ (Packer et al.,
2003). CD-1 femaleswere obtained fromCharles
River Laboratories. For staging of embryos, mid-
day of the vaginal plug was calculated as embry-
onic day 0.5 (E0.5). Littermate mice, either male
or female (wild-type [WT]or,whennot possible,
heterozygous)were used as controls for all exper-
iments. Mouse colonies were maintained in ac-
cordance with the guidelines set by the author’s
institutions and theNational Institutes ofHealth.
For embryonic brains (E13.5, E15.5), ani-
mals were deeply anesthetized, dissected, and
fixed by immersion in 4% PFA in PBS over-
night at 4°C. The following day, tissue was
cryoprotected by immersion in 30% sucrose,
embedded in OCT (Tissue-Tek), cryostat
sectioned (20 m), and used either for in
situ hybridization or immunohistochemistry
analysis.
In situ hybridization. Section in situ hybridiza-
tion experiments were performed using digoxi-
genin riboprobeson20mfrozensections (from
either male or females) as described previously
(Jeong et al., 2004). The probes used and their
sources are as follows:Gucy1A3 (GenBank acces-
sion no. NM_021896), NOS1 (GenBank acces-
sion no. BF536292), andNOS3 (GenBank accession no. BC052636). cDNA
clones were purchased from imaGenes. An EST clone corresponding to
Gucy1B3 (GenBank accession no. BF472368), and cDNAclone correspond-
ing to NOS2 (GenBank accession no. BC062378) were purchased from
Open Biosystems.
Immunohistochemistry. Immunohistochemistry was performed on
cryostat sections (20m, fromeither sex) according toZhao et al. (2008).
The primary antibody that was used was rabbit anti-calbindin (CB) (1:
1000; Swant). Immunoperoxidase staining was performed by using the
ImmPRESS reagent kit (Vector Laboratories). The quantification of
calbindin-expressing cortical interneurons in E15.5 and P0, WT, and
Gucy1A3/mice was performed on 10 images. Boxes were drawn in
the subventricular zone (SVZ) or the cortical plate; the numbers of cells
were counted manually. All results are expressed as the mean  SE of
sample size n 3. Data were analyzed using Student’s t test or one-way
ANOVA followed by Bonferroni post test to determine the level of sig-
nificance. p 0.05 was considered significant, and p 0.01 was consid-
ered highly significant.
Pharmacological compounds. 8-Br-cGMP (a cGMP analog), ODQ (1
H- (1,2,4)oxadiazole (4,3-a)quinoxalin-1-one), guanylate cyclase inhib-
itor, and KT5823 (protein kinase G [PKG] inhibitor) were all purchased
fromEnzo Life Sciences. NAME86 (NG-monomethyl-L-arginine,mono-
acetate salt) was purchased from Calbiochem. Y-27632 was purchased
from Sigma. C3 transferase, calpeptin, and EGF were all purchased from
Cytoskeleton.
Slice culture and electroporation. Slices (300 m) were prepared from
E13.5 mouse embryos (from either male or female) (Anderson et al.,
1997a). Electroporations (pCAGGS-GFP) followed themethods of Stu¨h-
mer et al. (2002).
Matrigel explant assay. The 250 m coronal vibratome sections were
made from E13.5 WT, CD-1 telencephalons (from either sex), followed
by microdissection of theMGE and CGE progenitor zones. The explants
were embedded in Matrigel and placed into a 6-well insert (1 m pore
size) coated with Matrigel. Fresh slice culture medium, containing dif-
ferent pharmacological inhibitors/analogs, including ODQ, KT5823,
NAME86, and 8-Br-cGMP, were added, and then incubated at 37°Cwith
5% CO2 for 48 h, followed by fixation with 4% PFA, Hoechst 33258
staining, and imaging with a CoolSNAP EZ Turbo 1394 digital camera
(Photometric) on a Nikon ECLIPSE 80i microscope (Nikon Instru-
ments). Using theAdobe PhotoshopCS3 lasso tool, we drew two outlines
around the explant core (original size) and the perimeter of where cells
had migrated. The Hoechst-stained total explant area (after outgrowth)
was divided by the area of the explant core to assess migration from the
explant; results were presented as percentage of explant outgrowth, nor-
malized to control or DMSO-treated explants. We used 4 or 5 explants
per embryo, and a total of 2 or 3 embryoswere examined per condition in
Figure 1. Dlx1/2 regulate the expression of Gucy1A3, Gucy1B3, and Nos1 (nNOS) in the developing basal ganglia. In situ RNA
hybridization analysis of Gucy1A3 (A–D, E–H), Gucy1B3 (K–N,O–R), andNos1 (S–V) expression in the telencephalon ofWT
(left panels) andDlx1/2/ (right panels)mice at E13.5 and E15.5. In each case, four planes of hemisections are shown (rostral to
caudal).Gucy1A3 expression in theMGE is restricted to the dMGE. By E15.5,Gucy1A3 expression is detected in scattered cells in the
cortical SVZ (higher magnification in I–J below); this expression is reduced in the Dlx1/2/ mutants (I, J, arrows). Dlx1/
2/mutants also have reduced Gucy1A3 expression in the SVZ of the LGE andMGE (E13.5 and E15.5); in addition, at E15.5, the
mutants have ectopic Gucy1A3 expression in the caudoventral CGE/MGE (H, E*, arrows), the region that has ectopic interneuron
migration (Long et al., 2009b). Gucy1B3 andNos1 expression is also greatly reduced in the basal ganglia anlage of the Dlx1/2/
mutants. CGE, Caudal ganglionic eminence; CX, cortex; GP, globus pallidus; Str, striatum. Scale bars: A–H, K–V, 500m;
I–J, 120m.
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each experiment. All results are expressed as the mean  SE of sample
size n 3. Data were analyzed using Student’s t test or one-way ANOVA
followed by Bonferroni post test to determine the level of significance.
p 0.05 was considered significant, and p 0.01 was considered highly
significant.
Primary cell culture. Primary cultures were made from WT, CD-1, or
Lhx6-GFP animals (of either sex) dissociated anteriorMGE (VZ/SVZ) as
described previously (Xu et al., 2004; Cobos et al., 2005). After a day in
culture, the cells were exposed to DMSO or drug (e.g., ODQ); 30 min
later, the cells were fixed and studied by immunofluorescence.
Immunocytochemistry. Immunofluorescence on dissociated cells (Xu et
al., 2004) using the following primary antibodies: mouse anti--III-tubulin
(Tuj1) (1:1000; Covance), chicken anti-GFP (1:1000; Aves Laboratories).
Secondary antibodies were as follows: Alexa-488 goat anti-mouse (1:500),
Alexa-488 goat anti-chicken (1:500) (Invitrogen).
Boyden chamber assay.Dissociated MGE cells (E13.5 animals of either
sex) were plated on a filter of Boyden chamber inserts (BD Biosciences)
with an 8mpore size in a 24-well format. A total of 7 103 cells in 200
l Neurobasal medium supplemented with B27 were added to the top
chamber. Cell migration was promoted by adding 10% FBS to the lower
compartment of the chamber. Cultures were incubated for 19–22 h with
different pharmacological inhibitors/analogs in both chambers. Cells
that had remained on the top of the filter were eliminated with a cotton
tip. The filters were then stained using HEMA3 stat pack (Protocol). The
filter’s lower side was imaged on a Nikon ECLIPSE 80i microscope
(Nikon Instruments) and counted using Im-
ageJ software (National Institutes of Health) in
five randomly selected fields. For Dlx1/2/
mutants, we used 3WT and 3mutant embryos
per experiment. For all other Boyden assays, we
used 7 WT embryos per experiment. Three in-
dependent experiments were performed. Cell
migration is displayed as percentage of cells
migrating normalized to control or DMSO-
treated wells. All results are expressed as the
mean  SE of sample size n  3. Data were
analyzed using Student’s t test or one-way
ANOVA followed by Bonferroni post test to
determine the level of significance. p  0.05
was considered significant, and p  0.01 was
considered highly significant.
Real-time imaging.Coronal E15.5 Lhx6-GFP
brain slices (200 m, from either males or fe-
males) were treated with DMSO or ODQ for
12 h. After drug treatment, the slices were
placed onto nucleopore membrane filters over
35 mm glass-bottom dishes containing MEM
(Invitrogen) and 10% FBS. Mounted slices
were immediately transferred to a 37°C/5%
CO2 live tissue incubation chamber attached to
a Zeiss inverted microscope and a PASCAL
confocal laser scanning system and imaged re-
peatedly every 12min for up to 20 h. Real-time
interneuronal migration patterns were quanti-
fied using Zeiss LSM Image Browser software.
Statistical analysis was performedwith the Stu-
dent’s t test using Prism4 software (GraphPad
Software).
Protein preparation and Western blotting.
MGE cells were lysed in RIPA buffer contain-
ing protease inhibitors (Roche). Western blot
was performed as described previously (Cobos
et al., 2007). Each experiment was repeated at
least three times. The intensity of the bands
was quantified using the histogram feature in
Adobe Photoshop (CS3). Using the marquee
tool in Photoshop, a box was drawn covering
one band, and the mean intensity of the value
was recorded. The size of the box was consis-
tent throughout the analysis. The mean value
was then subtracted from the background. Results were presented as
either absolute mean values or percentage of relative protein levels, nor-
malized to control or DMSO-treated cell extracts. Primary antibodies
used were obtained from Cell Signaling Technology: rabbit vasodilator-
stimulated phosphoprotein (VASP) (1:1000); rabbit anti-pVASP-Ser 239
(1:1000), and rabbit anti-phospho-myosin light chain 2 (Ser 19) (1:400).
Quantification of neurite length. Quantification of neurite length was
performed in immature interneurons from brain slices (200 m) or
MGE primary cultures prepared with Lhx6-GFP or WT embryos (from
either male or females), immunostained for GFP or Tuj1, respectively.
Images from brain slices were acquired on a confocal microscope (LSM
510 META NLO, Carl Zeiss) with a 63  objective. Series of z-stack
images (3–5 optical series) were collected, encompassing all neuronal
processes of each cell. The length of the longest neurite was quantified
using Zeiss LSM Image Browser software. Neurite length of immature
interneurons from MGE primary cultures was assessed on digitized
images obtained with a CoolSNAP EZ Turbo 1394 digital camera (Photo-
metric) on a Nikon ECLIPSE 80i microscope (Nikon Instruments) using a
40 objective. Digitized images were imported to ImageJ (National Insti-
tutes of Health software) for tracing and quantifying neurites. Experimental
results were expressed as length of the longest neurite normalized toDMSO
control. Data were analyzed using Student’s t test or one-way ANOVA fol-
lowed byBonferroni post test to determine the level of significance. p 0.05
was considered significant, and p 0.01 was considered highly significant.
Figure 2. Lhx6 regulates the expression of Gucy1A3 in the dorsal MGE. In situ RNA hybridization analysis of Gucy1A3 expression
in the telencephalon of Lhx6/PLAP (heterozgyotes) (left panels) and Lhx6PLAP/PLAP (homozygote mutants) (right panels) mice at
E13.5 (A–D) and E15.5 (E–H). In each case, four planes of hemisections are shown (rostral to caudal). Expression of Gucy1A3 is
specifically lost from the dMGE (B, F). I–T, Expression of NOS1 (nNOS), NOS2, and NOS3 in the developing basal ganglia of WT
and Dlx1/2/ E15.5 mice. In situ RNA hybridization analysis of NOS1 (I–L), NOS2 (M–P), and NOS3 (Q–T) expression in the
telencephalon ofWT (left panels) andDlx1/2/ (right panels)mice at E15.5. In each case, four planes of hemisections are shown
(rostral to caudal). Scale bars: A–T, 500m.
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Statistical analysis. All results are expressed
as the mean  SE of sample size n  3. Data
were analyzed using a Student’s t test or a one-
way ANOVA followed by Bonferroni post test
to determine the level of significance. p 0.05
was considered significant (*), and p  0.01
was considered highly significant (**).
Results
Soluble guanylate cyclase and NO
synthase (NOS) expression in the
developing telencephalon
To elucidate the molecular mechanisms
underlying the subpallial migration de-
fects in theDlx1/2/mutants (Anderson
et al., 1997a, b; Cobos et al., 2007; Long et
al., 2007), we previously identified dys-
regulated genes in the E15.5 GEs using
RNA expression array analysis (Cobos et
al., 2007; Long et al., 2009a,b). One of the
most prominent downregulated genes
was Gucy1A3, encoding the 1 subunit of
sGC. Gucy1A3 RNA was reduced 3.5-
fold in the Dlx1/2/ mutant, which was
confirmed by in situRNAhybridization at
E13.5 and E15.5 (Fig. 1A–H).
In WT mice, Gucy1A3 RNA was ex-
pressed in most cells of the E13.5 SVZ of
the lateral ganglionic eminence (LGE),
MGE, and CGE. Within the MGE, its ex-
pression was largely restricted to the dorsal
MGE (dMGE), the part of the MGE that is
largely responsible for generating pallial in-
terneurons (Fig. 1B,B) (Fogarty et al.,
2007; Flandin et al., 2010). On the other
hand, theventralMGE(vMGE),whichgen-
erates the globus pallidus (Flandin et al.,
2010), had low Gucy1A3 expression (Fig.
1C,C). In the E13.5 Dlx1/2/ mutant,
Gucy1A3 expression was greatly reduced
(Fig. 1A–D).
At E15.5, Gucy1A3 expression was
maintained in the GEs (again at very low
levels in the vMGE) and was more prom-
inently expressed in the subpallial mantle
zone (MZ), particularly in the striatal neurons (Gucy1A3 expres-
sion was not detected in the globus pallidus). In the Dlx1/2/
mutant, SVZ expression was strongly reduced and MZ expres-
sion was moderately decreased (Fig. 1E–H). Ectopic subpallial
expression (E*) (Fig. 1H) was observed in a caudoventral region;
previous analysis showed that this region expressed markers of
immature interneurons (e.g., Lhx6) that had failed to migrate to
the cortex (Long et al., 2009b).
Lhx6 and Lhx6/8mutants have defects in interneuron migra-
tion, including a prominent dMGE ectopia corresponding to a
collection of unmigrated cells (Zhao et al., 2008; Flandin et al.,
2011). In the Lhx6 null mutant (E13.5 and E15.5), Gucy1A3 ex-
pression in the dMGE was greatly reduced (Fig. 2A–H), thus
providing further evidence for a link between Gucy1A3 and in-
terneuron migration.
In the pallium ofWTmice,Gucy1A3was expressed in cortical
plate (CP) and in scattered cells in the SVZ whose location is
consistent with tangentially migrating interneurons. Indeed, in
the Dlx1/2/ mutant, pallial SVZ expression was nearly elimi-
nated (Fig. 1I,J), supporting the idea that Gucy1A3 is expressed
in immature interneurons in the SVZ of the dMGE and as they
tangentially migrate to the cortex. These interneurons could also
be derived from the CGE, which also has high levels of Gucy1A3
expression (Fig. 1D,H).
Next, we assessed whether other guanylate cyclase subunits
were expressed in the E15.5 telencephalon. Similar to Gucy1A3,
RNA expression of Gucy1B3 was easily detected at E13.5 and
E15.5, where it was largely restricted to the LGE (SVZ and MZ)
and CP, with much lower expression in the CGE and MGE (Fig.
1N,R, L,M,P,Q). In the Dlx1/2/mutant, subpallial Gucy1B3
expression was nearly eliminated (Fig. 1K–N,O–R). While
Gucy1A3 andGucy1B3were the only sGC subunits with strong in
situ hybridization expression in the E15.5 subpallium, gene ex-
pression array analyses of E12.5 MGE, E15.5 MGE, and P0 cell-
sorted purified cortical interneurons detected expression of
Gucy1B2, Gucy1B3, and Gucy1A3, whereas Gucy1A2 expression
was not detected (Cobos et al., 2007; Stanco et al., unpublished
Figure 3. 8-Br-cGMPmediates a partial rescue of cell migration ofMGE and CGE cells from Dlx1/2/mutants assessed using
Matrigel explants and Boyden chamber assays.A–D, Matrigel explant cell migration assays of E13.5MGE and CGE comparingWT
(A–D) and Dlx1/2/mutants (A–D) treated with DMSO (A, A, C, C) or 8-Br-cGMP (B, B,D,D). E, F, Histograms reporting
thepercentage change in theMGE (E) andCGE (F ) explant outgrowth (normalized toDMSO). Data are themeanSEM. *p0.05
(paired Student’s t test). **p 0.01 (paired Student’s t test). Scale bars:A–D, 500m.A,A, p 0.02241;B,B, p 0.00884;
A,B, p 0.00246.G, Boyden chamber assay showing that 8-Br-cGMP partially rescues theDlx1/2/mutant ( p 0.02645).
*p 0.05. **p 0.01.
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observations). For instance, in P0 interneurons, Gucy1A3was the
most robustly expressed (5000 units), and Gucy1B2 and
Gucy1B3were expressed at similar levels (450 and1150 units,
respectively).
sGCs are activated by NO produced by NOSs (Knowles and
Moncada, 1994; Friebe and Koesling, 2003; Stothers et al., 2003;
Garthwaite, 2008). There are three NOS genes: NOS1 (nNOS),
NOS2, and NOS3; we studied their expression by in situ hybrid-
ization. At E13.5, NOS1 expression was detected in a ventral–
dorsal gradient in the MGE SVZ, in addition to expression in the
cortical plate (Fig. 1S–V). In the E13.5Dlx1/2/mutant,NOS1
expression in the MGE was lost (Fig. 1U). At E15.5, NOS1 ex-
pression in theWT subpalliumwas greatly reduced, with modest
expression in the MGE SVZ (Fig. 2K), whereas cortical expression
was strong, particularly in the SVZ and cortical plate (Fig. 2I–L).
NOS2 expression was difficult to discern because of high back-
ground; however, there appeared to be expression in the ventricular
zones of the cortex, LGE, dMGE, andCGE,with lower expression in
thevMGE(Fig. 2M–P). In theDlx1/2/mutants,NOS2expression
increased in the VZ of the LGE and dMGE (Fig. 2M–P).
NOS3 expression was prominent in blood vessels throughout
the telencephalon; this expression did not change in the Dlx1/
2/ mutants (Fig. 2Q–T). Thus, subpallial NO could be pro-
duced in the VZ by NOS2, in the MGE SVZ by NOS1, and
scattered throughout the subpallium by NOS3 in blood vessels.
Of these, only NOS1 expression was lost
in the Dlx1/2/ mutants. In summary,
Dlx1/2/mutants lose subpallial expres-
sion of Gucy1A3, Gucy1B3, and NOS1,
and thus could have an alteration of
cGMP-mediated cellular processes. To in-
vestigate whether these gene expression
changes could alter the properties of im-
mature cells in the GEs, we studiedmouse
mutants (Dlx1/2/, Gucy1A3/, and
NOS1/) and inhibitors of sGCs (ODQ),
NOS (NAME86), and PKG (a kinase acti-
vated by cGMP) (KT5823).
Migration defects ofDlx1/2/mutant
MGE and CGE cells are partially
rescued with 8-Br-cGMP, a cGMP
analog
Given the reduced subpallial expression of
Gucy1A3, Gucy1B3, and NOS1 in the
Dlx1/2/mutants, we hypothesized that
some of their cellular defects, such as mi-
gration, could be the result of changes in
cGMP signaling. To test this, we used two
migration assays (explant culture and
Boyden chamber) to determine whether
exposing the cells to the cell-permeable
cGMP analog (8-Br-cGMP) would par-
tially rescue their migration defect. Using
the explant assay, we confirmed thatDlx1/
2/mutant MGE and CGE (E13.5) had
greatly reduced cellular migration (Fig.
3A,C) compared withWT explants (Fig.
3A,C). Addition of 8-Br-cGMP (500 M)
to the Dlx1/2/ mutant explants in-
duced outgrowth from the mutant MGE
and CGE (Fig. 3B,D). 8-Br-cGMP also
stimulated migration fromWTMGE and
CGE explants suggesting the cGMP is a positive regulator of mi-
gration (Fig. 3B,D). These results are quantified in Figure 3E, F.
In the Boyden chamber assay, 8-Br-cGMP did not stimulate mi-
gration of WT MGE cells but did stimulate migration of the
Dlx1/2/ mutant MGE cells (Fig. 3G). In the slice migration
assay, 8-Br-cGMP stimulated MGE tangential migration to the
cortex approximately twofold in WT slices (Fig. 4C–C, whereas
it did not rescue migration of Dlx1/2/ mutants (Fig. 4D–D),
probably because of the many defects in the Dlx1/2/mutants.
These results are quantified in Figure 4E.
Inhibition of sGC and PKG blocks migration from theMGE
and CGE
To investigate the role of sGCs in the tangential migration of
MGE- and CGE-derived interneurons, we used a specific inhibi-
tor of sGCs named ODQ (Boulton et al., 1995; Garthwaite et al.,
1995; Zhao et al., 2000; Cechova and Pajewski, 2004). We ana-
lyzed the effect of ODQ using slice (telencephalic), explants, and
Boyden chamber migration assays. In all three assays, ODQ in-
hibited migration in a dose-dependent manner.
The slice migration assay (using electroporation of GFP into
either the MGE or CGE) showed partial inhibition of tangential
migration with 25 MODQ (Fig. 5B,B,F,F,I) and nearly com-
plete inhibition with 50 M ODQ (Fig. 5C,C,G,G,I). The inhi-
bition of tangential migration in both MGE and CGE slices at 50
Figure 4. A–D, Slice electroporation migration assay. Cells were visualized by transfecting a GFP expression vector into the
MGE in either the WT (A–A, C–C) or the Dlx1/2/mutants (B–B, D–D) treated with DMSO or 8-Br-cGMP. Migration into
the LGE and cortexwas assessed after 24, 36, and 48h. E, Histogram showingquantification of the number of cellsmigrating to the
cortex fromMGE in slices. Data are themean SEM. *p 0.05 (paired Student’s t test). **p 0.01 (paired Student’s t test).A,
C, p 0.018; A, C, p 0.0006. Slices were grown in either DMSO or 8-Br-cGMP (500M). CX, Cortex. Scale bars: A–D,
500m.
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Figure 5. Inhibition of soluble guanlyate cyclase activity with ODQ reduces interneuron process length andmigration from the MGE and CGE to the cortex in E13.5 telencephalic slices. Movies 1
and 2 show additional data.A–H, Slice electroporationmigration assay. Cells were visualized by transfecting a GFP expression vector into either theMGE (A–D) or CGE (E–H) by electroporation;
migration into the LGE and cortex was assessed after 24 and 48 h. I, Histogram showing quantification of the number of cells migrating to the cortex fromMGE or CGE in slices. Slices were grown in
DMSO, 25MODQ, 50MODQ, or 100MODQ. Data are themean SEM. *p 0.05 (one-wayANOVA followedbyBonferroni post test). **p 0.01 (one-wayANOVA followedbyBonferroni post
test). A, A, p 1.1 E-6; B, B, p 0.00001; A, C, p 0.00358; A,D, p 0.00142; E, E, p 1.3 E-6; F, F, p 0.00003; E, G, p 0.00016; E,H, p 0.00037. CX, Cortex. Scale
bars:A–H, 500m. J,K, Confocal image showing Lhx6-GFP expression in an E15.5 brain slice (200m) treatedwith either DMSOor ODQ (100M) for 1 h. L–O, Interneurons from the CP, oriented
in a radial (L,M ) or tangential (N,O) direction, are aligned by their cell soma (yellow arrowhead). The leading process lengthwas assessed from the base of the soma to the tip of the leading process
(red arrowhead). P, Quantification of rates of tangential migration through theMZ and SVZ are based on live imaging of E15.5 Lhx6-GFP ODQ-treated and DMSO-treated control cortices for 12 h.
MZ,p4.01 E-7; SVZ,p1.84 E-8.Q, Quantificationof thenumber ofmotile cells (i.e., cellsmigratingat a rate of	5m/h)within theCPofODQ-treatedandDMSO-treated control cortices
( p 0.00021). R, S, Quantification of leading process length of interneurons oriented in either radial or tangential direction (N 5). *p
 0.001 (Student’s t test). R, p 1.16 E-5. S, p
0.00043. Scale bars: J, K, 110m; L,M, 28m;N,O, 30m. T, Matrigel explant cell migration assays of E13.5 MGE showing the outgrowth of neurites/cell processes (-III-tubulin) (U, V ) and
migration of the soma/nucleus (Hoechst) (U, V) treatedwith DMSO (U,U) or ODQ (100M) (V, V). Bottom, Histograms reporting the percentage change in theMGE explant outgrowth. Data
are the mean SEM. *p
 0.05 (paired Student’s t test). **p
 0.01 (paired Student’s t test). U, V, p 0.00011; U, V, p 5.1 E-6.
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and 100MODQat 48 hwas statistically significant as quantified
in Figure 5I. Similar results were obtained with the explant cul-
ture assay (70% inhibitionwith 50MODQ) (Fig. 6A–J);more
modest inhibition was detected with the Boyden chamber assay
(30% inhibition with 50 M ODQ,60% with 100 M ODQ)
(Fig. 6K). Next, we assessed whether we could rescue the ODQ-
induced migration deficits by adding 8-Br-cGMP (500 M) to
ODQ in the Boyden chamber assay. 8-Br-cGMP partially coun-
teracted the effect of 50 and 100MODQ.However, the rescue in
migration by 8-Br-cGMP was statistically significant in 100 M
ODQ (Fig. 6L).
To assess the effect at the single-cell level of reducing Gucy
function, we treated slices from an E15.5 Lhx6-GFP-Bac mouse
(Cobos et al., 2005, 2007) with ODQ (100
M) for 1 h and studied the morphology
of migrating GFP cortical interneurons.
ODQ clearly attenuated the length of the
tangential and radial leading processes
(Fig. 5J–O,R,S); similar rapid responses
were also observed in dissociated MGE
cells (see Figs. 11A–I and 13A,D).
Next, we comparedmigration rates us-
ing live imaging of E15.5 Lhx6-GFP corti-
cal interneurons in ODQ-treated versus
DMSO-treated slices (imaging after 12 h
of ODQ treatment). ODQ resulted in an
approximately twofold decrease in the
rate of tangential migration through the
MZ and SVZ (Fig. 5P), with an approx-
imately twofold reduction in number
of CP motile cells (i.e., cells migrating at
a rate of 	5 m/h) (Fig. 5Q; Movies 1
and 2).
These results were supported using
the explant migration assay, where we
found that ODQ inhibited the migration
of both the soma/nucleus (Hoechst) (Fig.
5T,U,V) and the outgrowth of neurites/
cell processes (-III-tubulin) (Fig. 5T–V)
from the explants.
To assess whether the decreased mi-
gration was affected by changes in cell
proliferation, we measured the percent-
age of cells in M-phase of the cell cycle
using PH3 immunofluoresence in MGE-
dissociated cells; we found no significant
effect on the number of PH3 cells, even
up to 100 M ODQ (data not shown).
Furthermore, ODQ treatment did not
increase the number of apoptotic cells
(caspase-3 antibody staining; data not
shown). Thus, ODQ did not reduce the
numbers of migrating cells by altering
proliferation or cell death.
cGMP signaling is mediated in part
through activation of PKG (Wall et al.,
2003; Francis et al., 2010). We inhibited
PKG pharmacologically using KT5823
(Dora et al., 2001; Kwan et al., 2004; Nu-
gent et al., 2009) and assessed cell migra-
tion using the slice culture, Matrigel
explants, and Boyden chamber migration
assays. KT5823-mediated PKG inhibition
reduced migration in all the assays (Fig. 7A,B,C,D–L).
Gucy1A3/mutant mice have a transient reduction of
neocortical interneurons
Given that pharmacological inhibition of sGC with ODQ strongly
reduced neuronalmigration from theMGE, we tested the effect of a
loss of function mutation in Gucy1A3, one member of sGC family.
As noted above,Gucy1A3 subpallial expression is greatly reduced in
Dlx1/2/ (Fig. 1). Gucy1A3/ mice are viable and are not re-
ported tohaveepilepsy; therefore, it isunlikely that theyhavea severe
neuroanatomical defect. Indeed, calbindin (CB) interneuronsmi-
grating from the Gucy1A3/mutant MGE at E13.5 did not show
neurite or migration deficits (data not shown). However, at E15.5,
Figure 6. Inhibition of soluble guanlyate cyclase activity with ODQ blocks cell migration from E13.5 explants of the MGE and
CGE, assessed usingMatrigel explants and Boyden chamber assays. A–H, Matrigel explant cell migration assays of E13.5MGE and
CGE comparing DMSO (A, E), 25 M ODQ (B, F ), 50 M ODQ (C, G), and 100 M ODQ (D, H ). I, J, Histograms reporting the
percentage change in the MGE (I ) and CGE (J ) explant outgrowth as a function of ODQ dose using one-way ANOVA followed by
Bonferroni post test. I, DMSO versus ODQ 25M, p 0.01346; DMSO versus ODQ 50M, p 1.52 E-4; DMSO versus ODQ 100
M,p4.72 E-5. J, DMSOversusODQ25M,p0.01044; DMSOversusODQ50M,p0.00245; DMSOversusODQ100M,
p3.156 E-4. Scale bars:A–H, 500m.K, Boyden chamber assay showing that progressively increasing concentrationofODQ
inhibit more migration. Data are the mean SEM. *p 0.05 (one-way ANOVA followed by Bonferroni post test). **p 0.01
(one-wayANOVA followedbyBonferroni post test). DMSOversus ODQ25M, p0.02589; DMSOversus ODQ50M, p4.29
E-4; DMSO versus ODQ 100M, p 6.73 E-4. L, Boyden chamber assay showing that 8-Br-cGMP partially counteracted the
effect of 50 and100MODQ.However, the rescue inmigration by 8-Br-cGMPwas statistically significant in 100MODQ (p 0.03).
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we detected a50% reduction in the number of CB interneurons
in their cortex (Fig. 8A–C,D). At E15.5, CB is a marker of MGE-
derived interneurons (Flames et al., 2004). There was a 50% reduc-
tion in the deep migration zone (SVZ) and a 60% reduction in the
cortical plate.We did not assess themarginal zone numbers because
the CB cell density was too high. By P0,Gucy1A3/mutants had
a subtle reduction in CB interneurons in the rostral cortical plate
(data not shown).
Inhibition of NOS blocks migration from theMGE and CGE
NO activates cGMP production by sGC (Denninger and Mar-
letta, 1999; Lincoln et al., 2001; Ghalayini, 2004; Evgenov et al.,
2006; Stasch et al., 2011). Thus, we tested the effect of pharmaco-
logically inhibiting NOS activity using NAME86 (Regli et al.,
1996; Georgiadou and Pitsikas, 2011; Mohammadi et al., 2011)
on the migration of MGE- and CGE-derived interneurons us-
ing slice electroporation (Fig. 9A–F,G), explants, and Boyden
chamber migration assays (Fig. 10A–I). NAME86 treatment re-
duced migration in all three assays, although not to the extent
of 100 M ODQ (Figs. 9A–F,G and 10A–I ).
NO could be supplied from several sources (Fig. 2I–T), in-
cludingNOS1MGE cells and cortical plate cells and axons (Fig.
2K). Indeed, NOS1 axons are detected extending from the cor-
tical plate into the LGE/striatum (Fig. 9H); NO production from
these axons could regulate interneuron migration. The cortical
plate continued to express NOS1 RNA and protein (Figs.
2I–L and 10 J,K ) in Dlx1/2/mutants, as expected, because
neither Dlx1 nor Dlx2 is expressed in these cells. However, we
found that theNOS1 corticofugal axonswere greatly reduced in
the striatum of the Dlx1/2/ mutant (Fig. 10 J,K), consistent
with our paper showing that corticofugal fibers have a pathfind-
ing defect inDlx1/2/mutants secondary to defects in the LGE/
striatum (Garel et al., 2002).
Next, we assessed the effect of a loss of function NOS1
mutation on interneuron development (Packer et al., 2003).
We did not observe a clear change in interneuron migration
based on CB immunohistochemistry at E15.5 and P0 (data not
shown). The lack of a detectable phenotype could be the result
of NOS2 and NOS3 providing alternative sources of NO.
Inhibition of sGC rapidly alters the shape of MGE neurons via
the activation of the Rho signaling pathway
Tounderstand themechanisms bywhichODQ inhibition of sGC
impedes neuronal migration, we studied the shape of -III-
tubulin (Tuj1) MGE-derived neurons 30 min after ODQ treat-
ment. ODQ induced a clear dose-dependent attenuation of
neurite length (Fig. 11A–E), similar to what we observed in cor-
tical slice culture (Fig. 5J–S), and dissociated MGE culture of
Lhx6-GFP neurons (Fig. 12A–D). Importantly, ODQ attenua-
tion of neurite length was reversible when ODQ was removed
from the media (Fig. 11F–I). Furthermore, inhibition of tangen-
tial migration from the MGE to the cortex was also partially
reversible when ODQ was removed from the media in a slice
electroporation experiment (Fig. 11J–S). Thus, inhibition of sGC
rapidly reduced neurite length and could underlie the defects in
migration.
cGMP is known to modulate the cytoskeleton in several ways
(see Fig. 14). Increased cGMP levels inactivate theRhoA signaling
pathway (Sawada et al., 2001; Begumet al., 2002;Gudi et al., 2002;
Sauzeau et al., 2003, 2000). Furthermore, activated RhoA signal-
ing leads to neurite retraction, whereas inhibition of RhoA sig-
naling leads to neurite elongation (Hirose et al., 1998; Togashi et
al., 2000). Thus, it is possible that ODQ-mediated neurite retrac-
tion could be due to activated RhoA signaling. To test this hy-
pothesis, we performed a series of in vitro pharmacological assays
on MGE neuron neurite length (Figs. 13A–I,J and 14).
First, we tested whether ODQ (50 M) inhibition of neurite
length was counteracted by 8-Br-cGMP. Indeed, neurite length
was intermediate in cells exposed to 8-Br-cGMP and ODQ (Fig.
13B,D,E, J). Addition of 8-Br-cGMP to DMSO or ODQ-treated
MGE cells appeared to increase PKG activity (ameasure of cGMP
levels), as indicated by increased levels of phospho-VASP Ser239
by Western blot analysis (Fig. 12I); phospho-VASP Ser239 is a
recognized indicator of active PKG (Smolenski et al., 1998; Oelze
et al., 2000; Lawrence and Pryzwansky, 2001).
PKG inhibits RhoA activity (Sawada et al., 2001; Begum et al.,
2002; Gudi et al., 2002; Sauzeau et al., 2003, 2000) (Fig. 14). RhoA
Movie 1. Interneuron migration in the DMSO-treated Lhx6-GFP cerebral wall. Images
were obtained from the outlined region of embryonic cortical slices. Image orientation is indi-
cated by the arrows. GE, Ganglionic eminence; CX, dorsal cortex; VS, ventricular surface. In E15.5
DMSO-treated Lhx6-GFP control cortices, approximately one-third of Lhx6-GFP interneu-
ronswithin the cortical plate aremotile (i.e., cellsmigrating at a rate of	5m/h) and display
an elongated leading process. Time length 4.1 h. See also Figure 5, J, L, N, and P–S.
Movie 2. Interneuron migration in the ODQ-treated Lhx6-GFP cerebral wall. Within the
cortical plate, the number ofmotile interneurons and the leading process length of tangentially
and radially migrating interneurons are significantly decreased in E15.5 ODQ-treated Lhx6-
GFP cortices comparedwith DMSO-treated controls. Approximately 5 h after ODQ treatment,
interneuron leading process length andmotility return to control levels (data not shown). Time
length 3.9 h. GE, Ganglionic eminence; CX, dorsal cortex; VS, ventricular surface. See also
Figure 5, K, M, O, P–S.
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Figure 7. Inhibition of PKG activity with KT5823 reduces interneuronmigration from the MGE to the cortex in E13.5 telencephalic slices. A–B, Slice electroporation migration assay. Cells were
visualized by transfecting a GFP expression vector into theMGE (A–B) by electroporation;migration into the LGE and cortexwas assessed after 7, 19, and 41 h. C, Histogram showing quantification
of thenumber of cellsmigrating to the cortex fromMGE in slices. Slicesweregrown in eitherDMSOor 25MKT5823. CX, Cortex. Data are themeanSEM. *p0.05 (paired Student’s t test). **p
0.01 (paired Student’s t test). A, B, p 7.5 E-6. Additionally, inhibition of PKG activity with KT5823 inhibits cell migration from explants of the E13.5 MGE and CGE, assessed using Matrigel
explants and Boyden chamber assays. D–I, Matrigel explant cell migration assays of E13.5 MGE and CGE comparing DMSO (D, G), 100M ODQ (E, H ), and 25M KT5823 (F, I ). J, K, Histograms
reporting the percentage change in MGE (J ) and CGE (K ) explant outgrowth as a function of ODQ and KT5823 using one-way ANOVA followed by Bonferroni post test. DMSO versus ODQ, p
3.26E-07; DMSO versus KT, p 6.06E-07.K, DMSO versus ODQ, p 3.57E-05; DMSO versus KT, p 7.47E-05. L, Boyden chamber assay showing that both ODQ and KT5823 inhibitmigration. Data
are themean SEM. *p
0.05 (one-wayANOVA followedbyBonferroni post test). **p
0.01 (one-wayANOVA followedbyBonferroni post test). DMSOversusODQ,p1.4 E-6; DMSOversus
KT, p 2.1 E-5. Scale bars: A–I, 500m.
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mediates its effects through several pathways, including repres-
sion of Rac and CDC42 signaling (Sander et al., 1999;Wahl et al.,
2000; Sugimoto et al., 2003; Xu et al., 2003; Seasholtz et al., 2004;
Rosenfeldt et al., 2006; Burridge and Doughman et al., 2006) and
activation of Rho kinase (ROCK) (Ishizaki et al., 1996; Leung et
al., 1996, 1995; Matsui et al., 1996). Thus, we tested the effect of
pharmacological inhibition and activation of RhoA, activation of
Rac/CDC42, and inhibition of ROCK on MGE neurite length.
Figure 8. Gucy1A3/ mice have reduced numbers of calbindin cortical interneurons at E15.5. Calbindin immunohistochemistry staining of E15.5 coronal hemisections of WT (A–C) and
Gucy1A3/ (A–C) telencephalons showingmigrating immature cortical interneurons in rostral (A,A),middle (B,B), and caudal (C,C) planes of sections.D, Histogramshowingquantification
of calbindin cell numbers in the cortical SVZ and cortical plate. Data are themean SEM. *p 0.05 (one-way ANOVA followed by Bonferroni post test). **p 0.01 (one-way ANOVA followed
by Bonferroni post test). SVZ, WT versus Gucy1A3/ (rostral, p 0.00317; medial, p 0.00202; caudal, p 0.00344); cortical plate (caudal, p 0.00745). Scale bars: A–C, 200m.
Figure9. Inhibition of NOS activitywithNAME86 inhibits interneuronmigration fromE13.5 explants of theMGE and CGE, assessed using electroporation slice culturemigration assays. Cellswere
visualized by transfecting a GFP expression vector into either theMGE (A–C) or CGE (D–F) by electroporation;migration into the LGE and cortexwas assessed after 24 and 48 h. Slices were grown
in DMSO, 100M ODQ, or 100M NAME86.G, Histogram quantifying the number of cells migrating to the cortex fromMGE or CGE in slices. Data are themean SEM. *p 0.05 (one-way ANOVA
followed by Bonferroni post test). **p 0.01 (one-way ANOVA followed by Bonferroni post test).A,B, p 1.3 E-5;A, C, p 0.00014;D, E, p 0.00235;D, F, p 0.0396.H, NOS1
expression in E14.5WT sections. Arrows in the 20magnification image indicateNOS1 in corticofugal axons entering the striatum. CX, Cortex. Scale bars:A–F,H (left), 500m;H (right), 100m.
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The ROCK inhibitor alone (Y-27632) (Sahai et al., 1999;
Ishizaki et al., 2000) slightly increased neurite length, although
this was not statistically significant compared with DMSO. ODQ
in combination with Y-27632 resulted in neurite length that was
intermediate to cells exposed only to ODQ or Y-27632 (Fig.
13C,D,F,J). Thus, the partial rescue of ODQ-mediated neurite
retraction by 8-Br-cGMP provides evidence that cGMP signaling
promotes neurite length. Furthermore, the partial rescue of
ODQ-mediated neurite retraction by inhibition of the Rho path-
way (by the ROCK inhibitor, Y-27632) provides evidence that
Rho signaling inhibits neurite length.
To further investigate the role of RhoA signaling on MGE
neuron neurite length, we tested the effect of pharmacological
activation or inhibition of RhoA. The Rho
inhibitor C3 transferase (Nwariaku et al.,
2003; Krijnen et al., 2010) increased neu-
rite length, whereas the Rho activator cal-
peptin (Castellone et al., 2011; Xiang et al.,
2011) reduced neurite length (Fig.
13G,H, J). Thus, as predicted by the effect
of ROCK inhibition, RhoA activation re-
pressed neurite extension of immature
MGE neurons consistent with the model
in Figure 14.
As RhoA can repress Rac activity
(Burridge andDoughman et al., 2006), we
exploredwhether the effects onMGEneu-
ronal morphology, which occurred in re-
sponse to changes in RhoA activity, were
acting through Rac. Thus, we tested the
effect of activating Rac/CDC42 using EGF
(Kurokawa et al., 2004). However, EGF
treatment did not have a discernible effect
on neurite length (Fig. 13 I, J). Thus,
whereas activation of RhoA shortened
neurites, activation of Rac did not affect
MGE neurite length (at least through
EGF). Therefore, we have evidence that
cGMP can act through PKG repression of
RhoA signaling to increase neurite length
of immature MGE neurons.
To test this model, we expressed vari-
ous forms of RhoA in the slice migration
assay. Consistent with our hypothesis, a
dominant active RhoA (DA RhoA) inhib-
ited tangential migration (Fig. 13N,N,O),
whereas the dominant-negative RhoA (DN
RhoA) and the ROCK inhibitor (Y-27632)
did not inhibit MGE tangential migration
(Fig. 13L,L,M,M,O), compared with
DMSO-treated slices (Fig. 13K,K,O). Fur-
thermore, the constitutively activeRhoA in-
duced approximately twofold attenuation
in the neurite length of MGE immature
neurons (Fig. 13R). Similar migration re-
sults were obtained with the Boyden
chamber assay (approximately threefold in-
hibition with 50 M ODQ, approximately
sevenfold inhibition with the Rho activator
calpeptin, and approximately threefold in-
crease in migration with 10 M Y-27632
(Fig. 13T). To begin to understand how
cGMP modulates MGE neuron migration,
we investigated whether cGMP’s known effects on the cytoskeleton
also affected immature MGE neurons. In smooth muscle cells, in-
creases incGMPlevels increase theactivityofMLCP.MLCPdephos-
phorylates, and thereby reduces, the activity of the regulatoryMLC,
which results in reduced myosin activity and smooth muscle relax-
ation(Gongetal., 1996;Ottoet al., 1996;Fujiharaet al., 1997;Uehata
et al., 1997; Sekoet al., 2003;Hartshorneet al., 2004;Nakamuraet al.,
2007; Somlyo, 2007). Thus, cGMP-dependent phosphorylation
of MLCP reduces myosin activity and leads to smooth muscle
relaxation.
To explore whether immature MGE neurons respond simi-
larly to changes in cGMP levels, we studied the phosphorylation
state of MLC in response to ODQ. We observed increased MLC
Figure10. InhibitionofNOSactivitywithNAME86blocks cellmigration fromE13.5 explants of theMGEandCGE, assessedusing
Matrigel explants andBoyden chamber assays.A–F,Matrigel explant cellmigration assays of E13.5MGEandCGE comparingDMSO
(A,D), 100M ODQ (B, E), and 100MNAME86 (C, F ).G,H, Histograms reporting the percentage change inMGE (G) and CGE (H )
explant outgrowth as a function of ODQandNAME86using one-wayANOVA followedbyBonferroni post test.G, DMSOversusODQ,
p 1.54E-06; DMSO versus NAME, p 1.99E-06.H, DMSO versus ODQ, p 8.33E-04; DMSO versus NAME, p 2.84E-03. Scale
bars:A–F, 500m. I, Boyden chamber assay showing that both ODQ (100M) and NAME86 (100M) inhibitmigration. Data are
the mean SEM. *p 0.05 (one-way ANOVA followed by Bonferroni post test). **p 0.01 (one-way ANOVA followed by
Bonferroni post test). DMSO versus ODQ, p 1.17E-07; DMSO versus NAME, p 1.39E-05. J, K, Immunofluorescence analysis of
NOS1expression in the telencephalonofWT (J ) andDlx1/2/ (K )mice at E18.5. Arrows indicate the axonsgoing to striatum. CX,
Cortex; Str, striatum.
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phosphorylation (p-MLC Ser19) after ODQ treatment using im-
munofluorescence and Western blot analysis (Fig. 13U,X,Y).
ODQ increased the amount of p-MLC at the distal end of large
neurites (Fig. 13U compared with Fig. 13U), in contrast to cells
treated with 8-Br-cGMP (Fig. 13V) or Y-27632 (Fig. 13W).
Given that ROCK can repress the activity of MLC phosphatase
(Wang et al., 2011), we suggest that ODQ-mediated reduced
cGMP is increasing p-MLC through activating the RhoA signal-
ing pathway, as described above (Fig. 14, summary diagram).
Discussion
Toward identifying genes that are candidates for regulating
MGE neuronal differentiation and migration, we have inves-
tigated gene expression changes in the Dlx1/2/ and Lhx6/
Figure11. Inhibition of soluble guanylate cyclase rapidly alters the shape ofMGEneurons.A–D, Dose-dependent attenuation ofMGEneurite length comparingDMSO (A), 25MODQ (B), 50M
ODQ (C), and 100M ODQ (D) treated for 30min followed by staining using-III-tubulin (Tuj1) antibodies. Scale bars: A–D, 50m. E, Histogram showing the effect of different concentrations of
ODQ (A–D) on longest neurite length, normalized toDMSO.A versusB,p4.667105;A versusC,p5.378106;A versusD,p1.535107.F–H, ODQattenuation of neurite length
was reversiblewhenODQwaswashed from themedia as shown inH; comparewith F (DMSO) andG (50MODQ). Scale bars: F–H, 100m. I, Histogram showing the effect on neurite lengthwhen
ODQ was washed from the media, normalized to DMSO. F versus G, p 1.8 E-6; G versus H, p 3.4 E-6. J–R, Inhibition of tangential migration from the MGE to the cortex was partially
reversible when ODQ was removed from the media after 27 h of ODQ treatment, and image was taken 24 h after the ODQ wash in a slice electroporation experiment as shown in R compared with
the unwashed specimen inO. Also comparewithM–O (50MODQ) and J–L (DMSO). S, Histogramquantifying thenumber of cellsmigrating to the cortex fromMGE in slices. Scale bars: J–O, 500m.Data
arethemeanSEM.*p0.05(one-wayANOVAfollowedbyBonferroniposttest).**p0.01(one-wayANOVAfollowedbyBonferroniposttest).L,O,p1.13E-6;L,R,p4.5E-5;O,R,p0.0001.
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mousemutants (Zhao et al., 2008; Long et al., 2009a,b; Flandin et
al., 2011; McKinsey et al., 2013). Here we have focused on
Gucy1A3, whose expression in the SVZ of the rostrodorsal MGE
is greatly reduced in both mutants (Figs. 1 and 2). Gucy1A3 en-
codes a sGC whose activity is induced by NO to generate cGMP
(Denninger and Marletta, 1999; Lincoln et al., 2001; Ghalayini,
2004; Evgenov et al., 2006; Stasch et al., 2011).
Gucy1A3 is expressed at multiple stages of interneuron devel-
opment, including the SVZ of theMGE at the outset of tangential
migration (Fig. 1A–H) and during their migration in the cortex
based on P0 gene expression array data (Stanco and Rubenstein,
unpublished observations). Here we show that 8-Br-cGMP (a
cGMP analog) promotes MGE neuronal migration and that in-
hibition ofGucy1A3 (pharmacologically and genetically) reduces
migration (Figs. 3A,B,E, 4C–C, 5A–H, I,P,Q,U,V, 6A–K, and
8A–C,D; Movies 1 and 2). ODQ potently and rapidly causes
neurite retraction of immature MGE-derived neurons in MGE
slices and in dissociated cultures (Figs. 5J–O,R,S,U,V, 11A–I,
12A–D, and 13A,D).
As with any pharamacological agent, one needs to be circum-
spect about its specificity; however, we are unaware of known
off-target effects of ODQ at the concentrations we are using.
Furthermore, the ODQ-induced phenotypes are remarkably
similar to those observed with pharmacological inhibition of
components of the cGMP signaling pathway that lie either up-
stream (NO generation) or downstream (PKG, Rho, ROCK) to
Gucy1A3 (Figs. 7A–C, 9A–F,G, 10A–I, and 13A–J,P–S). There-
fore, the results of this study are internally consistent with the
conclusion that NO-mediated activation of cGMP synthesis by
sGC promotes neurite extension and cell migration.
Genetic analysis also supports our model, as the Gucy1A3/
mutant has a reduction of CB interneurons in its E15.5 cortex
(Fig. 8A–D). This phenotype is not as penetrant as the effects of
ODQ on tangential migration from the MGE and CGE (Fig. 5A–
I). However, as is common in mammalian genetic studies, ge-
netic redundancy could compensate for the functional loss of one
member of the gene family. Indeed, RNA arrays detected
Gucy1B2, Gucy1B3, and Gucy1A3 expression in the E12.5 and
E15.5MGE, as well as in cell-sorter-purified P0 cortical interneu-
rons (Cobos et al., 2007; Stanco et al., unpublished observations).
Therefore, it is likely that the mild phenotype of theGucy1A3/
mutant is due to genetic compensation.
NO activates cGMP production by sGCs. Pharmacological
inhibition of NO production reduced migration in slice and ex-
plant cultures, as well as the Boyden chamber assay (Figs. 9A–
F,G and Fig. 10A–I). This provides supportive and independent
evidence that sGC function is important for MGE migration.
Whereas the Nos1/mutant mouse did not show a clear defect
inMGE interneuronmigration (data not shown),Nos2 andNos3
are also expressed in the developing telencephalon (Fig. 2M–T).
These homologs may generate sufficient NO to support cGMP
production by the sGCs.
Figure 12. Inhibition of sGC rapidly alters the neurite length of MGE neurons that were labeled by GFP expression from an Lhx6-GFP-Bac transgene. A–H, Dose-dependent attenuation of MGE
neurite length comparing DMSO (A), 25M ODQ (B), 50M ODQ (C), and 100M ODQ (D) followed by the partial rescue in ODQ-induced neurite length by the addition of 8-Br-cGMP (E–H ). Scale
bars: A–H, 50m. I, Western blot analysis showing increased levels of phospho-VASP Ser 239 (a measure of PKG activity) in MGE cells treated with either 8-Br-cGMP alone or in combination with
ODQ comparedwith DMSO or ODQ alone treated cells. Total VASP (tVASP) was used as the loading control. J, Quanitification of theWestern blot bands using the histogram tool in Adobe Photoshop
(CS3). Results are presented as relative protein levels, expressed in percentage normalized to DMSO-treated cell extracts.
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Figure 13. Inhibition of sGC activity with ODQ mediates neurite retraction via the activation of Rho signaling pathway. A–F, ODQ inhibition of neurite length (D) is counteracted by either
8-Br-cGMP (B, E, J ) or the ROCK inhibitor Y-27632 (C, F, J ). G–J, The RhoA inhibitor C3 transferase (G) and the Rac activator EGF (I ) increased neurite length. On the other hand, the RhoA activator
calpeptin reduced neurite length (H ). Scale bars:A–I, 50m. Results are quantified in J. J, DMSO versus ODQ, p 6.855 108; ODQ versus ODQ 8-Br, p 0.0296; ODQ versus ODQ Y, p
1.288 104; DMSO versus calpeptin, p 8.756 1012. K–N, Slice electroporation migration assay. Cells were visualized by transfecting a GFP expression vector (K, K, M, M) or
cotransfecting a GFP expression vectorwith constitutively active RhoA (CA RhoA) (N,N), dominant-negative RhoA (DNRhoA) (L, L) into theMGE (K–N) by electroporation;migration into the LGE
and cortexwas assessed after 7 and 40 h.O, Histogram showing quantification of the number of cellsmigrating to the cortex fromMGE in slices. Sliceswere grown in either DMSO or 10M Y-27632
as indicated. Expression of a constitutively active RhoA (CA RhoA) inhibited tangential migration (N, N) significantly, whereas the dominant-negative RhoA (DN RhoA) and the ROCK inhibitor
(Y-27632) did not inhibit MGE tangential migration (L, L,M,M). Instead, therewas a significant increase in themigration.K,K, p 3.9 E-10; L, L, p 4.41 E-8;M,M, p 1.23 E-8;
K, L, p 0.00042; K,M, p 0.01142; K,N, p 3.76 E-9. CX, Cortex. Scale bars: K–N, 500m. P–R, Expression of a constitutively active RhoA (CA RhoA) (R) construct in MGE neurons
reduced the neurite length significantly compared with control (P) or dominant-negative RhoA (DN RhoA) construct (Q). S, Histogram showing the effect on neurite length when dominant active
or negative RhoA constructs were expressed inMGE neurons. P versus R, p 0.00031. Scale bars: P–R, 50m. T, Boyden chamber assay showing that both ODQ and the Rho activator (calpeptin)
inhibit migration in contrast to Y-27632 (ROCK inhibitor). DMSO versus ODQ, p 0.0002; DMSO versus Y, p 0.00039; DMSO versus Rho Act, p 5.1 E-7. (Figure legend continues.)
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Signals other thanNOmay also regulate sGC activity inMGE-
derived neurons. For instance, Sema3A can activate sGC
(Schmidt et al., 2002; Nishiyama et al., 2003, 2008, 2011; Togashi
et al., 2008; Shelly et al., 2011). These studies of Sema3A-
mediated increased cGMP levels have focused on axon guidance
and axon/dendrite specification, where cGMP regulates the neu-
ron’s response through activating cyclic nucleotide-gated cal-
ciumchannels (Nishiyama et al., 2008, 2011; Togashi et al., 2008).
Thus, we assessed whether repressing sGC activity in MGE neu-
rons in vitro with ODQ affected calcium levels using calcium
indicator dyes and fluorescence microscopy. However, we did
not detect clear changes in calcium-mediate fluctuations after
ODQ treatment (data not shown), suggest-
ing that cGMP-mediated effects on MGE
neuron morphology and migration may be
primarily mediated by the RhoA pathway,
as discussed below. Nonetheless, additional
studies are needed to investigate whether
changes in cGMP concentrations regulate




Thirty minutes of ODQ treatment of
MGE cells in dissociated culture, or 1 h in
slice culture, resulted in rapid and robust
shortening of neurite length (Figs. 5J–
O,R,S, 11A–E, 12A–D, and 13A,D,J).
This effect was partially reversed using
8-Br-cGMP (Figs. 12E–H and 13B,E,J),
providing evidence that neurite retraction
was caused by inhibiting cGMP produc-
tion (and thereby reducing active PKG).
Furthermore, ODQ’s effect was also par-
tially reversed by the ROCK inhibitor
Y-27632 (Fig. 13C,F, J), suggesting that
neurite retraction was caused by activa-
tion of RhoA/ROCK signaling. This
hypothesis was supported by results ob-
tained by expression of dominant active
RhoA that reduced neurite length and
tangential migration of MGE immature
neurons (Fig. 13P–S). We summarize our
postulation of the pathway in a schema
(Fig. 14). Most information on the mech-
anisms of how NO/cGMP signaling
controls the cytoskeleton and cellular
movement comes from work in non-
neural cells, particularly smooth muscle
(for review, see Pfitzer, 2001). ROCK in-
creases the phosphorylation of the regula-
tory subunit of myosin (pMLC), through
inhibiting MLCP (for review, see Pfitzer, 2001). Increased levels
of pMLC increase myosin II activity. For instance, RhoA/ROCK
signaling in cerebellar granule neurons activated myosin II activ-
ity, which in turn inhibited neurite outgrowth (Kubo et al., 2008).
These results are in concordance with our findings in imma-
ture MGE neurons. We found that inhibition of cGMP signaling
with ODQ reduced neurite length (Figs. 5, 11, 12, and 13). This
effect was partially reversed with the ROCK inhibitor (Y-27632)
(Fig. 13). Furthermore, whereas 8-Br-cGMP decreased the level
of pMLC, ODQ increased pMLC levels (Fig. 13V,U).
Thus, we propose that sGC generation of cGMP promotes
neurite extension and migration of subpallial-derived interneu-
rons by blocking RhoA/ROCK activity (Figs. 12, 13, and 14). This
model, summarized in Figure 14, has several ramifications, as
interneuron migration is regulated by repulsive cues that
cause neurite retraction. For instance, there is evidence that
semaphorin3A/3F expression in the striatum and cerebral cortex
repel migrating interneurons (Marín et al., 2001; Tamamaki et
al., 2003). Thus, we predict that cGMP could counteract
semaphorin-mediated repulsion. Another prediction is that NO-
producing tissues would promote interneuron migration. NOS1
is expressed in the cortical plate (Fig. 1S–V); thus cortical plate
Figure14. Schematic diagramproposing themechanismof cGMP(generatedby sGC)mediatedneurite extensionvia inhibition
of the Rho signaling pathway in MGE neurons.
4
(Figure legend continued.) U–W, Increased p-MLC phosphorylation staining at distal ends
of neurites after ODQ treatment comparedwith 8-Br-cGMPor Y-27632-treated cells. Scale bars:
U–W, 50 m. X, Western blot analysis showing increased p-MLC (Ser 19) phosphorylation
after ODQ treatment inMGE cells. tVASPwasused as the loading control.Y, Quantification of the
Western blot bands using the histogram tool in Adobe Photoshop (CS3). Results are presented
as relative protein levels, expressed in percentage normalized to DMSO-treated cell extracts.
Data are the mean SEM. J, O, S, T, *p 0.05 (one-way ANOVA followed by Bonferroni post
test). **p 0.01 (one-way ANOVA followed by Bonferroni post test).
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neurons and their processes (including axons projecting through
the basal ganglia; Fig. 9H) could be a source of NO that would
promote interneuron neurite extension and migration.
Our analysis of sGC function during the development of the
subpallium, and its derivatives such as cortical interneurons, adds
new insights into the molecular mechanisms underlying the cel-
lular phenotypes of cells lacking Dlx1/2 or Lhx6. We suggest that
sGC regulation of cGMP levels is integrated with the other sig-
naling systems that control the differentiation and migration of
cortical interneurons, including those downstream of CXCR4,
CXCR7, ErbB4, Neuropilin, and Pak3 (Marín et al., 2001; Tama-
maki et al., 2003; Flames et al., 2004; Cobos et al., 2007; Fogarty et
al., 2007; No´brega-Pereira et al., 2008; Sa´nchez-Alcan˜iz et al.,
2011;Wang et al., 2011). It is clear that no single signaling system
regulates each step in the maturation and migration of subpallial
cells, explaining why the phenotypes of Dlx1/2 or Lhx6 mutants
aremore severe and, in some cases, qualitatively distinct from the
effects of mutations, or pharmacological inhibition of sGCs or
single components of the other signaling systems.
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